{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:32:13Z","timestamp":1790613133859,"version":"4.1.0"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016132","name":"Walloon Region","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016132","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ejpb.2026.115035","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T23:09:37Z","timestamp":1772320177000},"page":"115035","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Optimizing spray-dried liposomes for pulmonary delivery: impact of lipids composition and of drying parameters using experimental design"],"prefix":"10.1016","volume":"223","author":[{"given":"Laure-Anne","family":"Bya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuan Nghia","family":"Dinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00e9mie","family":"Penoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7113-758X","authenticated-orcid":false,"given":"Pierre-Yves","family":"Sacr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Bottero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3079-7941","authenticated-orcid":false,"given":"Didier","family":"Cataldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Hendrickx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Conrard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Evrard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9raldine","family":"Piel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6586-8896","authenticated-orcid":false,"given":"Anna","family":"Lechanteur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2026.115035_b0005","volume":"Vol. 69","author":"Bashyal","year":"2025","journal-title":"Liposomal Drug Delivery System for Lung Diseases: Recent Advancement and Future Perspectives. in Nanomedicine: Nanotechnology, Biology, and Medicine"},{"key":"10.1016\/j.ejpb.2026.115035_b0010","doi-asserted-by":"crossref","unstructured":"Pasero, L., Susa, F., Limongi, T., & Pisano, R. (2024). A Review on Micro and Nanoengineering in Powder-Based Pulmonary Drug Delivery. In International Journal of Pharmaceutics (Vol. 659). Elsevier B.V. Doi: 10.1016\/j.ijpharm.2024.124248.","DOI":"10.1016\/j.ijpharm.2024.124248"},{"issue":"5","key":"10.1016\/j.ejpb.2026.115035_b0015","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1039\/D4PM00176A","article-title":"Advances in liposomal nanotechnology: from concept to clinics","volume":"1","author":"Senjab","year":"2024","journal-title":"RSC Pharmaceutics"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115035_b0020","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17030329","article-title":"Effects of surface charge of inhaled liposomes on drug efficacy and biocompatibility","volume":"17","author":"Zhang","year":"2025","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115035_b0025","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1021\/acsnano.4c11693","article-title":"Inhalable mucociliary-on-chip system revealing pulmonary clearance dynamics in nanodrug delivery","volume":"19","author":"Lin","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejpb.2026.115035_b0030","doi-asserted-by":"crossref","unstructured":"X. Yan, X. Sha, Nanoparticle-Mediated Strategies for Enhanced Drug Penetration and Retention in the Airway Mucosa, in: Pharmaceutics (Vol. 15, Number 10), Multidisciplinary Digital Publishing Institute (MDPI), 2023, Doi: 10.3390\/pharmaceutics15102457.","DOI":"10.3390\/pharmaceutics15102457"},{"key":"10.1016\/j.ejpb.2026.115035_b0035","doi-asserted-by":"crossref","unstructured":"D. Cipolla, I. Gonda, H.K. Chan, Liposomal formulations for inhalation, in Therapeutic Delivery, Vol. 4, Number 8, pp. 1047\u20131072, Newlands Press Ltd., 2013, Doi: 10.4155\/tde.13.71.","DOI":"10.4155\/tde.13.71"},{"key":"10.1016\/j.ejpb.2026.115035_b0040","doi-asserted-by":"crossref","unstructured":"X. Xu, F. Tian, Y. Pan, T. Zhang, L. Deng, H. Jiang, J. Han, J. Liu, Y. Zhao, W. Liu, Emerging mechanistic insights into liposomal stability: Full process management from production and storage to food application, Chemical Engineering Journal, Vol. 505, Elsevier B.V., 2025, Doi: 10.1016\/j.cej.2025.159552.","DOI":"10.1016\/j.cej.2025.159552"},{"issue":"7","key":"10.1016\/j.ejpb.2026.115035_b0045","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13071023","article-title":"Post-processing techniques for the improvement of liposome stability","volume":"13","author":"Yu","year":"2021","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115035_b0050","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000445116","article-title":"Liposome delivery systems for inhalation: a critical review highlighting formulation issues and anticancer applications","volume":"25","author":"Rudokas","year":"2016","journal-title":"Med. Princ. Pract."},{"key":"10.1016\/j.ejpb.2026.115035_b0055","doi-asserted-by":"crossref","unstructured":"Shahin, H. I., & Chablani, L. (2023). A comprehensive overview of dry powder inhalers for pulmonary drug delivery: Challenges, advances, optimization techniques, and applications. In Journal of Drug Delivery Science and Technology (Vol. 84). Editions de Sante. Doi: 10.1016\/j.jddst.2023.104553.","DOI":"10.1016\/j.jddst.2023.104553"},{"key":"10.1016\/j.ejpb.2026.115035_b0060","doi-asserted-by":"crossref","unstructured":"B. Chaurasiya, Y.Y. Zhao, Dry powder for pulmonary delivery: a comprehensive review, In Pharmaceutics, Vol. 13, Number 1, pp. 1\u201328, MDPI AG, 2021, Doi: 10.3390\/pharmaceutics13010031.","DOI":"10.3390\/pharmaceutics13010031"},{"key":"10.1016\/j.ejpb.2026.115035_b0065","doi-asserted-by":"crossref","unstructured":"A. Negi, S. Nimbkar, J.A. Moses, Engineering inhalable therapeutic particles: conventional and emerging approaches, in Pharmaceutics (Vol. 15, Number 12). Multidisciplinary Digital Publishing Institute (MDPI), 2023, Doi: 10.3390\/pharmaceutics15122706.","DOI":"10.3390\/pharmaceutics15122706"},{"key":"10.1016\/j.ejpb.2026.115035_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106158","article-title":"Particle engineering in dry powders for inhalation","volume":"172","author":"Scherlie\u00df","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115035_b0075","doi-asserted-by":"crossref","unstructured":"Spahn, J. E., Zhang, F., & Smyth, H. D. C. (2022). Mixing of dry powders for inhalation: A review. In International Journal of Pharmaceutics (Vol. 619). Elsevier B.V. Doi: 10.1016\/j.ijpharm.2022.121736.","DOI":"10.1016\/j.ijpharm.2022.121736"},{"key":"10.1016\/j.ejpb.2026.115035_b0080","doi-asserted-by":"crossref","unstructured":"N. Alhajj, N.J. O\u2019Reilly, H. Cathcart, Designing enhanced spray dried particles for inhalation: A review of the impact of excipients and processing parameters on particle properties, In Powder Technology (Vol. 384, pp. 313\u2013331), 2021, Elsevier B.V. Doi: 10.1016\/j.powtec.2021.02.031.","DOI":"10.1016\/j.powtec.2021.02.031"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115035_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12010055","article-title":"Influence of composition and spray-drying process parameters on carrier-free DPI properties and behaviors in the lung: a review","volume":"12","author":"Lechanteur","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115035_b0090","doi-asserted-by":"crossref","unstructured":"Vishali, D. A., Monisha, J., Sivakamasundari, S. K., Moses, J. A., & Anandharamakrishnan, C. (2019). Spray freeze drying: Emerging applications in drug delivery. In Journal of Controlled Release (Vol. 300, pp. 93\u2013101). Elsevier B.V. Doi: 10.1016\/j.jconrel.2019.02.044.","DOI":"10.1016\/j.jconrel.2019.02.044"},{"key":"10.1016\/j.ejpb.2026.115035_b0095","doi-asserted-by":"crossref","unstructured":"A. Ziaee, A.B. Albadarin, L. Padrela, T. Femmer, E. O\u2019Reilly, G. Walker, Spray drying of pharmaceuticals and biopharmaceuticals: critical parameters and experimental process optimization approaches, in: Eur. J. Pharm. Sci., 2019, 127, pp. 300\u2013318, Elsevier B.V. Doi: 10.1016\/j.ejps.2018.10.026.","DOI":"10.1016\/j.ejps.2018.10.026"},{"key":"10.1016\/j.ejpb.2026.115035_b0100","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jconrel.2016.06.028","article-title":"Freeze-dried mucoadhesive polymeric system containing pegylated lipoplexes: towards a vaginal sustained released system for siRNA","volume":"236","author":"Furst","year":"2016","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115035_b0105","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s11095-012-0892-4","article-title":"Freeze-dried mannitol for superior pulmonary drug delivery via dry powder inhaler","volume":"30","author":"Kaialy","year":"2013","journal-title":"Pharm. Res."},{"issue":"4","key":"10.1016\/j.ejpb.2026.115035_b0110","doi-asserted-by":"crossref","first-page":"285","DOI":"10.15171\/PS.2017.42","article-title":"Physical characteristics of liposomal formulation dispersed in HPMC matrix and freeze-dried using maltodextrin and mannitol as lyoprotectant","volume":"24","author":"Nugraheni","year":"2017","journal-title":"Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115035_b0115","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17010122","article-title":"Development of spray-dried micelles, liposomes, and solid lipid nanoparticles for enhanced stability","volume":"17","author":"Dattani","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115035_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.tifs.2024.104412","article-title":"Strategies for further stabilization of lipid-based delivery systems with a focus on solidification by spray-drying","volume":"146","author":"Safaeian Laein","year":"2024","journal-title":"Trends Food Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115035_b0125","doi-asserted-by":"crossref","unstructured":"P. Goldbach, H. Brochart, A. Stamm, Spray-drying of liposomes for a pulmonary administration, I. Chemical stability of phospholipids, In Drug Development and Industrial Pharmacy, 1993, Vol. 19, Number 19.","DOI":"10.3109\/03639049309047204"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115035_b0130","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/jps.21972","article-title":"Structural effects caused by spray- and freeze-drying of liposomes and bilayer disks","volume":"99","author":"Wessman","year":"2010","journal-title":"J. Pharm. Sci."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2026.115035_b0135","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ijpharm.2012.08.046","article-title":"Cyclodextrin as membrane protectant in spray-drying and freeze-drying of PEGylated liposomes","volume":"438","author":"Van Den Hoven","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"12","key":"10.1016\/j.ejpb.2026.115035_b0140","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16121541","article-title":"Investigation of spray drying parameters to formulate novel spray-dried proliposome powder formulations followed by their aerosolization performance","volume":"16","author":"Khan","year":"2024","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115035_b0145","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ejps.2013.05.012","article-title":"Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer","volume":"49","author":"Meenach","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.ejpb.2026.115035_b0150","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1517\/17425247.2011.553219","article-title":"Stabilization of liposomes during drying","volume":"8","author":"Ingvarsson","year":"2011","journal-title":"Expert Opinion on Drug Delivery"},{"key":"10.1016\/j.ejpb.2026.115035_b0155","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejpb.2023.01.002","article-title":"Use of supercritical CO2 for the sterilization of liposomes: study of the influence of sterilization conditions on the chemical and physical stability of phospholipids and liposomes","volume":"183","author":"Delma","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115035_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122212","article-title":"An innovative one step green supercritical CO2 process for the production of liposomes co-encapsulating both a hydrophobic and a hydrophilic compound for pulmonary administration","volume":"627","author":"Penoy","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115035_b0165","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1208\/s12249-017-0841-y","article-title":"Study of the emitted dose after two separate inhalations at different inhalation flow rates and volumes and an assessment of aerodynamic characteristics of indacaterol onbrez breezhaler\u00ae 150 and 300\u03bcg","volume":"19","author":"Abadelah","year":"2018","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2026.115035_b0170","doi-asserted-by":"crossref","unstructured":"R.W. Dal Negro, Dry powder inhalers and the right things to remember: a concept review, in: Multidisciplinary Respiratory Medicine (Vol. 10, Number 1). BioMed Central Ltd., 2015, Doi: 10.1186\/s40248-015-0012-5.","DOI":"10.1186\/s40248-015-0012-5"},{"key":"10.1016\/j.ejpb.2026.115035_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121319","article-title":"Engineered-inhaled particles: Influence of carbohydrates excipients nature on powder properties and behavior","volume":"613","author":"Lechanteur","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115035_b0180","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"In Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.ejpb.2026.115035_b0185","doi-asserted-by":"crossref","unstructured":"J.O. Eloy, M. Claro de Souza, R. Petrilli, J.P.A. Barcellos, R.J. Lee, J.M. Marchetti, Liposomes as carriers of hydrophilic small molecule drugs: Strategies to enhance encapsulation and delivery, in Colloids and Surfaces B: Biointerfaces, 123, Elsevier, 2014, pp. 345\u2013363, Doi: 10.1016\/j.colsurfb.2014.09.029.","DOI":"10.1016\/j.colsurfb.2014.09.029"},{"key":"10.1016\/j.ejpb.2026.115035_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.120093","article-title":"A supercritical fluid technology for liposome production and comparison with the film hydration method","volume":"592","author":"Penoy","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115035_b0195","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-05948-4","article-title":"Optimized spray-drying of zinc sulfate-loaded liposomes: physicochemical characterization and in vitro release assessment","volume":"15","author":"Abbassi","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2026.115035_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123798","article-title":"The interplay between trehalose and dextran as spray drying precursors for cationic liposomes","volume":"652","author":"Lutta","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115035_b0205","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cryobiol.2020.12.009","article-title":"Enhancing the preservation of liposomes: the role of cryoprotectants, lipid formulations and freezing approaches","volume":"98","author":"Susa","year":"2021","journal-title":"Cryobiology"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115035_b0210","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.ijpharm.2015.09.052","article-title":"Interest of cyclodextrins in spray-dried microparticles formulation for sustained pulmonary delivery of budesonide","volume":"495","author":"Dufour","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115035_b0215","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejpb.2023.08.010","article-title":"Inhalation powder development without carrier: how to engineer ultra-flying microparticles?","volume":"191","author":"Lechanteur","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/j.ejpb.2026.115035_b0220","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jconrel.2004.02.010","article-title":"Cyclodextrins as a potential carrier in drug nebulization","volume":"96","author":"Evrard","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2026.115035_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2021.112577","article-title":"Assessment of in vitro kinetics and biological impact of nebulized trehalose on human bronchial epithelium","volume":"157","author":"Iskandar","year":"2021","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejpb.2026.115035_b0230","doi-asserted-by":"crossref","unstructured":"D. Zillen, M. Beugeling, W.L.J. Hinrichs, H.W. Frijlink, F. Grasmeijer, Natural and bioinspired excipients for dry powder inhalation formulations, in: Current Opinion in Colloid and Interface Science, Vol. 56, Elsevier Ltd., 2021, Doi: 10.1016\/j.cocis.2021.101497.","DOI":"10.1016\/j.cocis.2021.101497"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115035_b0235","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics8040036","article-title":"Evaluation of extrusion technique for nanosizing liposomes","volume":"8","author":"Ong","year":"2016","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115035_b0240","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1229829","article-title":"Evaluation of a static mixer as a new microfluidic method for liposome formulation","volume":"11","author":"Ota","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"11","key":"10.1016\/j.ejpb.2026.115035_b0245","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14112464","article-title":"Processing of lipid nanodispersions into solid powders by spray drying","volume":"14","author":"Steiner","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115035_b0250","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jconrel.2022.09.021","article-title":"Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery","volume":"351","author":"Zimmermann","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2026.115035_b0255","doi-asserted-by":"crossref","unstructured":"Poozesh, S., Connaughton, P., Sides, S., Lechuga-Ballesteros, D., Patel, S. M., & Manikwar, P. (2025). Spray drying process challenges and considerations for inhaled biologics. In Journal of Pharmaceutical Sciences (Vol. 114, Number 2, pp. 766\u2013781). Elsevier B.V. Doi: 10.1016\/j.xphs.2024.11.028.","DOI":"10.1016\/j.xphs.2024.11.028"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115035_b0260","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.bbapap.2013.01.020","article-title":"Unraveling protein stabilization mechanisms: Vitrification and water replacement in a glass transition temperature controlled system","volume":"1834","author":"Grasmeijer","year":"2013","journal-title":"Biochim. Biophys. Acta - Proteins and Proteomics"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115035_b0265","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/10942910500269824","article-title":"Glass transition and crystallization of amorphous trehalose-sucrose mixtures","volume":"8","author":"Roe","year":"2005","journal-title":"Int. J. Food Prop."},{"issue":"5","key":"10.1016\/j.ejpb.2026.115035_b0270","article-title":"Chemical analysis and molecular modelling of cyclodextrin-formulated propofol and its sodium salt to improve drug solubility","volume":"16","author":"Wilhelms","year":"2023","journal-title":"Stability and Pharmacokinetics (Cytogenotoxicity). Pharmaceuticals"},{"issue":"6","key":"10.1016\/j.ejpb.2026.115035_b0275","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1080\/03639040802526805","article-title":"Production and characterization of a spray-dried hydroxypropyl-\u03b2- cyclodextrinquercetin complex spray-dried hydroxypropyl-\u03b2-cyclodextrin\/ quercetin complex","volume":"35","author":"Zheng","year":"2009","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2026.115035_b0280","doi-asserted-by":"crossref","unstructured":"Z. Hammoud, N. Khreich, L. Auezova, S. Fourmentin, A. Elaissari, H. Greige-Gerges, Cyclodextrin-membrane interaction in drug delivery and membrane structure maintenance, in International Journal of Pharmaceutics, 2019, Vol. 564, pp. 59\u201376, Elsevier B.V. Doi: 10.1016\/j.ijpharm.2019.03.063.","DOI":"10.1016\/j.ijpharm.2019.03.063"},{"issue":"6","key":"10.1016\/j.ejpb.2026.115035_b0285","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25061435","article-title":"A theoretical study on trehalose + water mixtures for dry preservation purposes","volume":"25","author":"Kumar","year":"2020","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115035_b0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175478","article-title":"Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of niemann-pick disease type C1","volume":"12","author":"Yergey","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2026.115035_b0295","doi-asserted-by":"crossref","unstructured":"M. Danaei, M. Dehghankhold, S. Ataei, F. Hasanzadeh Davarani, R. Javanmard, A. Dokhani, S. Khorasani, M.R. Mozafari, Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems, in Pharmaceutics (Vol. 10, Number 2). MDPI AG. Doi: 10.3390\/pharmaceutics10020057, 2018.","DOI":"10.3390\/pharmaceutics10020057"},{"key":"10.1016\/j.ejpb.2026.115035_b0300","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ejps.2016.08.058","article-title":"PEGylation of lipoplexes: the right balance between cytotoxicity and siRNA effectiveness","volume":"93","author":"Lechanteur","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115035_b0305","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejpb.2022.01.009","article-title":"Elucidating inhaled liposome surface charge on its interaction with biological barriers in the lung","volume":"172","author":"Zhao","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115035_b0310","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa2504544","article-title":"As-needed albuterol\u2013budesonide in mild asthma","volume":"393","author":"LaForce","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.ejpb.2026.115035_b0315","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1002\/jps.22160","article-title":"Inhalable liposomes of low molecular weight heparin for the treatment of venous thromboembolism","volume":"99","author":"Bai","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115035_b0320","doi-asserted-by":"crossref","unstructured":"P. Muralidharan, E. Mallory, M. Malapit, H. Don, H.M. Mansour, Inhalable PEGylated phospholipid nanocarriers and PEGylated therapeutics for respiratory delivery as aerosolized colloidal dispersions and dry powder inhalers, Pharmaceutics 6(2) (2014) 333\u2013353, MDPI AG, Doi: 10.3390\/pharmaceutics6020333.","DOI":"10.3390\/pharmaceutics6020333"},{"issue":"39","key":"10.1016\/j.ejpb.2026.115035_b0325","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.1039\/D2SM00806H","article-title":"Impact of poly(ethylene glycol) functionalized lipids on ordering and fluidity of colloid supported lipid bilayers","volume":"18","author":"Giakoumatos","year":"2022","journal-title":"Soft Matter"},{"key":"10.1016\/j.ejpb.2026.115035_b0330","doi-asserted-by":"crossref","unstructured":"Li, J., Wang, X., Zhang, T., Wang, C., Huang, Z., Luo, X., & Deng, Y. (2015). A review on phospholipids and their main applications in drug delivery systems. In Asian Journal of Pharmaceutical Sciences (Vol. 10, Number 2, pp. 81\u201398). Shenyang Pharmaceutical University. Doi: 10.1016\/j.ajps.2014.09.004.","DOI":"10.1016\/j.ajps.2014.09.004"},{"issue":"6","key":"10.1016\/j.ejpb.2026.115035_b0335","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11060272","article-title":"Optimization of polyarginine-conjugated PEG lipid grafted proliposome formulation for enhanced cellular association of a protein drug","volume":"11","author":"Tunsirikongkon","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115035_b0340","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.actbio.2020.12.061","article-title":"Inhalable PLGA microspheres: Tunable lung retention and systemic exposure via polyethylene glycol modification","volume":"123","author":"Li","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2026.115035_b0345","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jconrel.2018.07.001","article-title":"PEGylated enhanced cell penetrating peptide nanoparticles for lung gene therapy","volume":"285","author":"Osman","year":"2018","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115035_b0350","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/jps.21441","article-title":"Physicochemical characterization and stability of rifampicin liposome dry powder formulations for inhalation","volume":"98","author":"Changsan","year":"2009","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115035_b0355","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1021\/ed100444h","article-title":"Prediction of log P: ALOGPS application in medicinal chemistry education","volume":"89","author":"Kujawski","year":"2012","journal-title":"J. Chem. Educ."},{"key":"10.1016\/j.ejpb.2026.115035_b0360","unstructured":"DrugBank. (2025). DrugBank Online. https:\/\/go.drugbank.com\/drugs\/DB01001."},{"key":"10.1016\/j.ejpb.2026.115035_b0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125696","article-title":"Formulation of a dry powder for inhalation combining ciclesonide and indacaterol maleate using spray drying","volume":"678","author":"Bya","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115035_b0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114134","article-title":"The role of PEGylation in the pulmonary delivery of antifibrotic liposomal therapies","volume":"386","author":"Pi\u00f1ol-Cancer","year":"2025","journal-title":"J. Control. Release"},{"issue":"10","key":"10.1016\/j.ejpb.2026.115035_b0375","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1111\/j.2042-7158.2012.01521.x","article-title":"Investigation into the effect of varying l -leucine concentration on the product characteristics of spray-dried liposome powders","volume":"64","author":"Chen","year":"2012","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2026.115035_b0380","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jfoodeng.2017.12.005","article-title":"Chitosan coated liposome dispersions loaded with cacao hull waste extract: effect of spray drying on physico-chemical stability and in vitro bioaccessibility","volume":"223","author":"Altin","year":"2018","journal-title":"J. Food Eng."},{"key":"10.1016\/j.ejpb.2026.115035_b0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2019.125951","article-title":"Effect of chitosan coating on the properties of nanoliposomes loaded with flaxseed-peptide fractions: Stability during spray-drying","volume":"310","author":"Sarabandi","year":"2020","journal-title":"Food Chem."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115035_b0390","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/10717540490265243","article-title":"The effect of different lipid components on the in vitro stability and release kinetics of liposome formulations","volume":"11","author":"Anderson","year":"2004","journal-title":"Drug Delivery: J. Deliv. Targeting Therapeutic Agents"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115035_b0395","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1208\/s12249-010-9442-8","article-title":"Effect of cholesterol on the properties of spray-dried lysozyme-loaded liposomal powders","volume":"11","author":"Charnvanich","year":"2010","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115035_b0400","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00408-011-9360-x","article-title":"Therapeutic liposomal dry powder inhalation aerosols for targeted lung delivery","volume":"190","author":"Willis","year":"2012","journal-title":"Lung"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115035_b0405","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13040563","article-title":"Ensuring homogeneity in powder mixtures for pharmaceuticals and dietary supplements: Evaluation of a 3-axis mixing equipment","volume":"13","author":"Marianni","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115035_b0410","first-page":"19","article-title":"Mechanistic time scales in adhesive mixing investigated by dry particle sizing","volume":"69","author":"Nguyen","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"12","key":"10.1016\/j.ejpb.2026.115035_b0415","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.4209\/aaqr.2020.02.0067","article-title":"Particle deposition in human lung airways: Effects of airflow, particle size, and mechanisms","volume":"20","author":"Ou","year":"2020","journal-title":"Aerosol Air Qual. Res."},{"key":"10.1016\/j.ejpb.2026.115035_b0420","doi-asserted-by":"crossref","unstructured":"Magramane, S., Vlahovi\u0107, K., Gordon, P., K\u00e1llai-Szab\u00f3, N., Zelk\u00f3, R., Antal, I., & Farkas, D. (2023). Inhalation Dosage Forms: A Focus on Dry Powder Inhalers and Their Advancements. In Pharmaceuticals (Vol. 16, Number 12). Multidisciplinary Digital Publishing Institute (MDPI). Doi: 10.3390\/ph16121658.","DOI":"10.3390\/ph16121658"},{"key":"10.1016\/j.ejpb.2026.115035_b0425","doi-asserted-by":"crossref","unstructured":"M.D. Louey, M. Van Oort, A.J. Hickey, Aerosol Dispersion of Respirable Particles in Narrow Size Distributions Using Drug-Alone and Lactose-Blend Formulations, 2004.","DOI":"10.1023\/B:PHAM.0000032991.74736.3e"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115035_b0430","doi-asserted-by":"crossref","DOI":"10.1208\/pt040454","article-title":"Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 aerodynamic par-ticle sizer aerosol spectrometer","volume":"4","author":"Mitchell","year":"2003","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115035_b0435","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/jps.23775","article-title":"Development and comparison of new high-efficiency dry powder inhalers for carrier-free formulations","volume":"103","author":"Behara","year":"2014","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115035_b0440","first-page":"1","volume":"9","author":"Braido","year":"2016","journal-title":"World Allergy Organ. J."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115035_b0445","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3109\/07853890.2011.585656","article-title":"Assessing and treating small airways disease in asthma and chronic obstructive pulmonary disease","volume":"44","author":"Usmani","year":"2012","journal-title":"Ann. Med."},{"key":"10.1016\/j.ejpb.2026.115035_b0450","doi-asserted-by":"crossref","unstructured":"Hillyer, E. V., Price, D. B., Chrystyn, H., Martin, R. J., Israel, E., van Aalderen, W. M. C., Papi, A., Usmani, O. S., & Roche, N. (2018). Harmonizing the Nomenclature for Therapeutic Aerosol Particle Size: A Proposal. In Journal of aerosol medicine and pulmonary drug delivery (Vol. 31, Number 2, pp. 111\u2013113). NLM (Medline). Doi: 10.1089\/jamp.2017.1396.","DOI":"10.1089\/jamp.2017.1396"},{"key":"10.1016\/j.ejpb.2026.115035_b0455","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.2147\/COPD.S269001","article-title":"Airway deposition of extrafine inhaled triple therapy in patients with copd: a model approach based on functional respiratory imaging computer simulations","volume":"15","author":"Usmani","year":"2020","journal-title":"Int. J. COPD"},{"key":"10.1016\/j.ejpb.2026.115035_b0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105600","article-title":"Enhancement of the extra-fine particle fraction of levofloxacin embedded in excipient matrix formulations for dry powder inhaler using response surface methodology","volume":"156","author":"Tse","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115035_b0465","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.2147\/IJN.S286896","article-title":"Development of inhalable nanostructured lipid carriers for ciprofloxacin for noncystic fibrosis bronchiectasis treatment","volume":"16","author":"Almurshedi","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2026.115035_b0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.powtec.2024.119576","article-title":"Enhancement of inhaled micronized powder flow properties for accurate capsules filling","volume":"437","author":"Gresse","year":"2024","journal-title":"Powder Technol."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115035_b0475","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1208\/s12248-025-01015-y","article-title":"Cannabidiol and hydroxypropyl-\u03b2-cyclodextrin for the development of deflated spherical-shaped inhalable powder","volume":"27","author":"Santos Gomes","year":"2025","journal-title":"AAPS J."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115035_b9000","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10159","article-title":"Inhalable bacteriophage powders: glass transition temperature and bioactivity stabilization","volume":"5","author":"Chang","year":"2020","journal-title":"Bioeng. Translational Med."},{"issue":"11","key":"10.1016\/j.ejpb.2026.115035_b9005","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11110616","article-title":"Be aggressive! amorphous excipients enabling single-step freeze-drying of monoclonal antibody formulations","volume":"11","author":"Haeuser","year":"2019","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115035_b9015","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/03639045.2020.1724131","article-title":"Hydroxypropyl beta cyclodextrin: a water-replacement agent or a surfactant upon spray freeze-drying of IgG with enhanced stability and aerosolization","volume":"46","author":"Milani","year":"2020","journal-title":"Drug Dev. Ind. Pharm."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126000561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126000561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T12:24:00Z","timestamp":1782822240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641126000561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":98,"alternative-id":["S0939641126000561"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115035","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing spray-dried liposomes for pulmonary delivery: impact of lipids composition and of drying parameters using experimental design","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115035"}}